Cenk Tek, MD
Enriched profileProfessor of Psychiatry; Director, Psychosis Program, Connecticut Mental Health Center · Yale School of Medicine
Cenk Tek is Professor of Psychiatry; Director, Psychosis Program, Connecticut Mental Health Center at Yale School of Medicine. OpenAlex indexes 99 publications with 4,306 citations (h-index 35); ClinicalTrials.gov lists 9 registered studies with this person as an investigator.
Data verified 16 Oct 2026
Overview
Updated 16 Oct 2026
Cenk Tek is Professor of Psychiatry at Yale School of Medicine. The public record shows 99 publications with 4,306 citations (h-index 35), centered on Schizophrenia research and treatment, Psychiatric care and mental health services, Mental Health Treatment and Access. It also documents an investigator role on 9 registered clinical trials, 2 NIH-funded awards (2009–2017).
- Most recent indexed publication: 2025 · The International journal of eating disorders
- Top research focus: Schizophrenia research and treatment
- 9 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 62.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia
Sponsor: Yale University
- Melatonin Treatment for Night-Eating Syndrome
Sponsor: Yale University
- A Pilot Trial of Curcumin Effects on Cognition in Schizophrenia
Sponsor: Yale University
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
87.9%Atypical Antipsychotic41.5%Clozapine59%Olanzapine12%Clozapine Odt6%Aripiprazole6%Risperidone5%Invega Sustenna4%Abilify Maintena4%Lurasidone Hcl2%Olanzapine Odt2%Part D<11 patientsAntihistamine11%Benztropine Mesylate86%Hydroxyzine Hcl15%Part D<11 patients+ 11 more classes in this area
Cardiovascular
4.4%Beta blocker3.7%Atenolol69%Propranolol Hcl31%Part D<11 patientsalpha-Adrenergic Blocker0.7%Prazosin Hcl100%Part D<11 patientsMetabolism & gastrointestinal
3.8%Biguanide (metformin)3.8%Metformin Hcl Er52%Metformin Hcl48%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
2 NIH research awards on record, funded 2009–2017 per NIH RePORTER. The latest:
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Cognitive-Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge-Eating Disorder: Secondary Outcomes of a Randomized Controlled Trial.
The International journal of eating disorders
Clinical Trial2025 - Decreased mitochondrial electron transport proteins and increased complement mediators in plasma neural-derived exosomes of early psychosis.
Translational psychiatry
Article2020
Most-cited works
by citation count (OpenAlex)- 01The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003Article765 citations2004
- 02Visual Perceptual and Working Memory Impairments in SchizophreniaArticle214 citations2002
- 03Religiosity and religious obsessions in obsessive–compulsive disorderArticle201 citations2001
- 04Prevalence of obesity and diabetes in patients with schizophreniaArticle180 citations2017
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/cenk-tek-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →yalemedicine.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Harlan Krumholz, MD
Yale School of Medicine
Eric Winer, MD
Yale School of Medicine
Roy Herbst, MD, PhD
Yale School of Medicine
Robert Rosenheck, MD
Yale School of Medicine
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Jeffrey Lieberman, MD
Columbia University College of Physicians and Surgeons